APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Endoparasiticide

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Endoparasiticide Market Analysis and Forecast 2026-2032

Report ID 173988270231 December 2025199 pages

Choose your research edition.

Industry ResearchEndoparasiticide Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Endoparasiticide Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Endoparasiticide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Endoparasiticide Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Endoparasiticide Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Endoparasiticide market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Endoparasiticide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Endoparasiticide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Endoparasiticide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Endoparasiticide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Endoparasiticide include Novartis AG, Merck, Eli Lilly, Bayer AG, Zoetis, Virbac, Vetoquinol, Elanco and Ceva Sante Animlae, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Endoparasiticide, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Endoparasiticide, also provides the sales of main regions and countries. Of the upcoming market potential for Endoparasiticide, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Endoparasiticide sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Endoparasiticide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Endoparasiticide sales, projected growth trends, production technology, application and end-user industry.

Endoparasiticide Segment by Company

Novartis AG

Merck

Eli Lilly

Bayer AG

Zoetis

Virbac

Vetoquinol

Elanco

Ceva Sante Animlae

Boehringer Ingelheim

Endoparasiticide Segment by Type

Ear Tags

Feed Additives

Tablets

Injectables

Endoparasiticide Segment by Application

Veterinary Hospitals or Clinics

Home Care Settings

Animal Farms

Endoparasiticide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endoparasiticide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Endoparasiticide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endoparasiticide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Endoparasiticide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Endoparasiticide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Endoparasiticide sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Endoparasiticide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Ear Tags Major Manufacturers Table 3. Feed Additives Major Manufacturers Table 4. Tablets Major Manufacturers Table 5. Injectables Major Manufacturers Table 6. Global Endoparasiticide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Veterinary Hospitals or Clinics Major Manufacturers Table 8. Home Care Settings Major Manufacturers Table 9. Animal Farms Major Manufacturers Table 10. Endoparasiticide Industry Trends Table 11. Endoparasiticide Industry Drivers Table 12. Endoparasiticide Industry Opportunities and Challenges Table 13. Endoparasiticide Industry Restraints Table 14. Global Endoparasiticide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Endoparasiticide Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Endoparasiticide Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Endoparasiticide Revenue Market Share by Region (2021-2026) Table 18. Global Endoparasiticide Revenue Market Share by Region (2027-2032) Table 19. Global Endoparasiticide Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Endoparasiticide Sales by Region (2021-2026) & (K Units) Table 21. Global Endoparasiticide Sales by Region (2027-2032) & (K Units) Table 22. Global Endoparasiticide Sales Market Share by Region (2021-2026) Table 23. Global Endoparasiticide Sales Market Share by Region (2027-2032) Table 24. Global Endoparasiticide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Endoparasiticide Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Endoparasiticide Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Endoparasiticide Sales Market Share by Manufacturers (2021-2026) Table 28. Global Endoparasiticide Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Endoparasiticide Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Endoparasiticide Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Endoparasiticide Manufacturers, Product Type & Application Table 32. Global Endoparasiticide Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Endoparasiticide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Endoparasiticide Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Endoparasiticide Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Endoparasiticide Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Endoparasiticide Revenue Market Share by Type (2021-2026) Table 39. Global Endoparasiticide Revenue Market Share by Type (2027-2032) Table 40. Global Endoparasiticide Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Endoparasiticide Sales by Type (2021-2026) & (K Units) Table 42. Global Endoparasiticide Sales by Type (2027-2032) & (K Units) Table 43. Global Endoparasiticide Sales Market Share by Type (2021-2026) Table 44. Global Endoparasiticide Sales Market Share by Type (2027-2032) Table 45. Global Endoparasiticide Price by Type (2021-2026) & (US$/Unit) Table 46. Global Endoparasiticide Price by Type (2027-2032) & (US$/Unit) Table 47. Global Endoparasiticide Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Endoparasiticide Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Endoparasiticide Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Endoparasiticide Revenue Market Share by Application (2021-2026) Table 51. Global Endoparasiticide Revenue Market Share by Application (2027-2032) Table 52. Global Endoparasiticide Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Endoparasiticide Sales by Application (2021-2026) & (K Units) Table 54. Global Endoparasiticide Sales by Application (2027-2032) & (K Units) Table 55. Global Endoparasiticide Sales Market Share by Application (2021-2026) Table 56. Global Endoparasiticide Sales Market Share by Application (2027-2032) Table 57. Global Endoparasiticide Price by Application (2021-2026) & (US$/Unit) Table 58. Global Endoparasiticide Price by Application (2027-2032) & (US$/Unit) Table 59. Novartis AG Company Information Table 60. Novartis AG Business Overview Table 61. Novartis AG Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Novartis AG Endoparasiticide Product Portfolio Table 63. Novartis AG Recent Development Table 64. Merck Company Information Table 65. Merck Business Overview Table 66. Merck Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Merck Endoparasiticide Product Portfolio Table 68. Merck Recent Development Table 69. Eli Lilly Company Information Table 70. Eli Lilly Business Overview Table 71. Eli Lilly Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Eli Lilly Endoparasiticide Product Portfolio Table 73. Eli Lilly Recent Development Table 74. Bayer AG Company Information Table 75. Bayer AG Business Overview Table 76. Bayer AG Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Bayer AG Endoparasiticide Product Portfolio Table 78. Bayer AG Recent Development Table 79. Zoetis Company Information Table 80. Zoetis Business Overview Table 81. Zoetis Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Zoetis Endoparasiticide Product Portfolio Table 83. Zoetis Recent Development Table 84. Virbac Company Information Table 85. Virbac Business Overview Table 86. Virbac Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Virbac Endoparasiticide Product Portfolio Table 88. Virbac Recent Development Table 89. Vetoquinol Company Information Table 90. Vetoquinol Business Overview Table 91. Vetoquinol Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Vetoquinol Endoparasiticide Product Portfolio Table 93. Vetoquinol Recent Development Table 94. Elanco Company Information Table 95. Elanco Business Overview Table 96. Elanco Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Elanco Endoparasiticide Product Portfolio Table 98. Elanco Recent Development Table 99. Ceva Sante Animlae Company Information Table 100. Ceva Sante Animlae Business Overview Table 101. Ceva Sante Animlae Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Ceva Sante Animlae Endoparasiticide Product Portfolio Table 103. Ceva Sante Animlae Recent Development Table 104. Boehringer Ingelheim Company Information Table 105. Boehringer Ingelheim Business Overview Table 106. Boehringer Ingelheim Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Boehringer Ingelheim Endoparasiticide Product Portfolio Table 108. Boehringer Ingelheim Recent Development Table 109. North America Endoparasiticide Revenue by Type (2021-2026) & (US$ Million) Table 110. North America Endoparasiticide Revenue by Type (2027-2032) & (US$ Million) Table 111. North America Endoparasiticide Sales by Type (2021-2026) & (K Units) Table 112. North America Endoparasiticide Sales by Type (2027-2032) & (K Units) Table 113. North America Endoparasiticide Sales Price by Type (2021-2026) & (US$/Unit) Table 114. North America Endoparasiticide Sales Price by Type (2027-2032) & (US$/Unit) Table 115. North America Endoparasiticide Revenue by Application (2021-2026) & (US$ Million) Table 116. North America Endoparasiticide Revenue by Application (2027-2032) & (US$ Million) Table 117. North America Endoparasiticide Sales by Application (2021-2026) & (K Units) Table 118. North America Endoparasiticide Sales by Application (2027-2032) & (K Units) Table 119. North America Endoparasiticide Sales Price by Application (2021-2026) & (US$/Unit) Table 120. North America Endoparasiticide Sales Price by Application (2027-2032) & (US$/Unit) Table 121. North America Endoparasiticide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. North America Endoparasiticide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. North America Endoparasiticide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. North America Endoparasiticide Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 125. North America Endoparasiticide Sales by Country (2021-2026) & (K Units) Table 126. North America Endoparasiticide Sales by Country (2027-2032) & (K Units) Table 127. North America Endoparasiticide Sales Price by Country (2021-2026) & (US$/Unit) Table 128. North America Endoparasiticide Sales Price by Country (2027-2032) & (US$/Unit) Table 129. United States Endoparasiticide Revenue (2021-2032) & (US$ Million) Table 130. Canada Endoparasiticide Revenue (2021-2032) & (US$ Million) Table 131. Europe Endoparasiticide Revenue by Type (2021-2026) & (US$ Million) Table 132. Europe Endoparasiticide Revenue by Type (2027-2032) & (US$ Million) Table 133. Europe Endoparasiticide Sales by Type (2021-2026) & (K Units) Table 134. Europe Endoparasiticide Sales by Type (2027-2032) & (K Units) Table 135. Europe Endoparasiticide Sales Price by Type (2021-2026) & (US$/Unit) Table 136. Europe Endoparasiticide Sales Price by Type (2027-2032) & (US$/Unit) Table 137. Europe Endoparasiticide Revenue by Application (2021-2026) & (US$ Million) Table 138. Europe Endoparasiticide Revenue by Application (2027-2032) & (US$ Million) Table 139. Europe Endoparasiticide Sales by Application (2021-2026) & (K Units) Table 140. Europe Endoparasiticide Sales by Application (2027-2032) & (K Units) Table 141. Europe Endoparasiticide Sales Price by Application (2021-2026) & (US$/Unit) Table 142. Europe Endoparasiticide Sales Price by Application (2027-2032) & (US$/Unit) Table 143. Europe Endoparasiticide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Europe Endoparasiticide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 145. Europe Endoparasiticide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 146. Europe Endoparasiticide Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 147. Europe Endoparasiticide Sales by Country (2021-2026) & (K Units) Table 148. Europe Endoparasiticide Sales by Country (2027-2032) & (K Units) Table 149. Europe Endoparasiticide Sales Price by Country (2021-2026) & (US$/Unit) Table 150. Europe Endoparasiticide Sales Price by Country (2027-2032) & (US$/Unit) Table 151. Germany Endoparasiticide Revenue (2021-2032) & (US$ Million) Table 152. France Endoparasiticide Revenue (2021-2032) & (US$ Million) Table 153. U.K. Endoparasiticide Revenue (2021-2032) & (US$ Million) Table 154. Italy Endoparasiticide Revenue (2021-2032) & (US$ Million) Table 155. Netherlands Endoparasiticide Revenue (2021-2032) & (US$ Million) Table 156. Nordic Countries Endoparasiticide Revenue (2021-2032) & (US$ Million) Table 157. China Endoparasiticide Revenue by Type (2021-2026) & (US$ Million) Table 158. China Endoparasiticide Revenue by Type (2027-2032) & (US$ Million) Table 159. China Endoparasiticide Sales by Type (2021-2026) & (K Units) Table 160. China Endoparasiticide Sales by Type (2027-2032) & (K Units) Table 161. China Endoparasiticide Sales Price by Type (2021-2026) & (US$/Unit) Table 162. China Endoparasiticide Sales Price by Type (2027-2032) & (US$/Unit) Table 163. China Endoparasiticide Revenue by Application (2021-2026) & (US$ Million) Table 164. China Endoparasiticide Revenue by Application (2027-2032) & (US$ Million) Table 165. China Endoparasiticide Sales by Application (2021-2026) & (K Units) Table 166. China Endoparasiticide Sales by Application (2027-2032) & (K Units) Table 167. China Endoparasiticide Sales Price by Application (2021-2026) & (US$/Unit) Table 168. China Endoparasiticide Sales Price by Application (2027-2032) & (US$/Unit) Table 169. Asia Endoparasiticide Revenue by Type (2021-2026) & (US$ Million) Table 170. Asia Endoparasiticide Revenue by Type (2027-2032) & (US$ Million) Table 171. Asia Endoparasiticide Sales by Type (2021-2026) & (K Units) Table 172. Asia Endoparasiticide Sales by Type (2027-2032) & (K Units) Table 173. Asia Endoparasiticide Sales Price by Type (2021-2026) & (US$/Unit) Table 174. Asia Endoparasiticide Sales Price by Type (2027-2032) & (US$/Unit) Table 175. Asia Endoparasiticide Revenue by Application (2021-2026) & (US$ Million) Table 176. Asia Endoparasiticide Revenue by Application (2027-2032) & (US$ Million) Table 177. Asia Endoparasiticide Sales by Application (2021-2026) & (K Units) Table 178. Asia Endoparasiticide Sales by Application (2027-2032) & (K Units) Table 179. Asia Endoparasiticide Sales Price by Application (2021-2026) & (US$/Unit) Table 180. Asia Endoparasiticide Sales Price by Application (2027-2032) & (US$/Unit) Table 181. Asia Endoparasiticide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 182. Asia Endoparasiticide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 183. Asia Endoparasiticide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 184. Asia Endoparasiticide Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 185. Asia Endoparasiticide Sales by Country (2021-2026) & (K Units) Table 186. Asia Endoparasiticide Sales by Country (2027-2032) & (K Units) Table 187. Asia Endoparasiticide Sales Price by Country (2021-2026) & (US$/Unit) Table 188. Asia Endoparasiticide Sales Price by Country (2027-2032) & (US$/Unit) Table 189. Japan Endoparasiticide Revenue (2021-2032) & (US$ Million) Table 190. South Korea Endoparasiticide Revenue (2021-2032) & (US$ Million) Table 191. India Endoparasiticide Revenue (2021-2032) & (US$ Million) Table 192. Australia Endoparasiticide Revenue (2021-2032) & (US$ Million) Table 193. China Taiwan Endoparasiticide Revenue (2021-2032) & (US$ Million) Table 194. Southeast Asia Endoparasiticide Revenue (2021-2032) & (US$ Million) Table 195. SAMEA Endoparasiticide Revenue by Type (2021-2026) & (US$ Million) Table 196. SAMEA Endoparasiticide Revenue by Type (2027-2032) & (US$ Million) Table 197. SAMEA Endoparasiticide Sales by Type (2021-2026) & (K Units) Table 198. SAMEA Endoparasiticide Sales by Type (2027-2032) & (K Units) Table 199. SAMEA Endoparasiticide Sales Price by Type (2021-2026) & (US$/Unit) Table 200. SAMEA Endoparasiticide Sales Price by Type (2027-2032) & (US$/Unit) Table 201. SAMEA Endoparasiticide Revenue by Application (2021-2026) & (US$ Million) Table 202. SAMEA Endoparasiticide Revenue by Application (2027-2032) & (US$ Million) Table 203. SAMEA Endoparasiticide Sales by Application (2021-2026) & (K Units) Table 204. SAMEA Endoparasiticide Sales by Application (2027-2032) & (K Units) Table 205. SAMEA Endoparasiticide Sales Price by Application (2021-2026) & (US$/Unit) Table 206. SAMEA Endoparasiticide Sales Price by Application (2027-2032) & (US$/Unit) Table 207. SAMEA Endoparasiticide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 208. SAMEA Endoparasiticide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 209. SAMEA Endoparasiticide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 210. SAMEA Endoparasiticide Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 211. SAMEA Endoparasiticide Sales by Country (2021-2026) & (K Units) Table 212. SAMEA Endoparasiticide Sales by Country (2027-2032) & (K Units) Table 213. SAMEA Endoparasiticide Sales Price by Country (2021-2026) & (US$/Unit) Table 214. SAMEA Endoparasiticide Sales Price by Country (2027-2032) & (US$/Unit) Table 215. Brazil Endoparasiticide Revenue (2021-2032) & (US$ Million) Table 216. Argentina Endoparasiticide Revenue (2021-2032) & (US$ Million) Table 217. Chile Endoparasiticide Revenue (2021-2032) & (US$ Million) Table 218. Colombia Endoparasiticide Revenue (2021-2032) & (US$ Million) Table 219. Peru Endoparasiticide Revenue (2021-2032) & (US$ Million) Table 220. Saudi Arabia Endoparasiticide Revenue (2021-2032) & (US$ Million) Table 221. Israel Endoparasiticide Revenue (2021-2032) & (US$ Million) Table 222. UAE Endoparasiticide Revenue (2021-2032) & (US$ Million) Table 223. Turkey Endoparasiticide Revenue (2021-2032) & (US$ Million) Table 224. Iran Endoparasiticide Revenue (2021-2032) & (US$ Million) Table 225. Egypt Endoparasiticide Revenue (2021-2032) & (US$ Million) Table 226. Key Raw Materials Table 227. Raw Materials Key Suppliers Table 228. Endoparasiticide Distributors List Table 229. Endoparasiticide Customers List Table 230. Research Programs/Design for This Report Table 231. Authors List of This Report Table 232. Secondary Sources Table 233. Primary Sources List of Figures Figure 1. Endoparasiticide Image Figure 2. Global Endoparasiticide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Endoparasiticide Market Size Share 2021 VS 2025 VS 2032 Figure 4. Ear Tags Image Figure 5. Feed Additives Image Figure 6. Tablets Image Figure 7. Injectables Image Figure 8. Global Endoparasiticide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Endoparasiticide Market Size Share 2021 VS 2025 VS 2032 Figure 10. Veterinary Hospitals or Clinics Image Figure 11. Home Care Settings Image Figure 12. Animal Farms Image Figure 13. Global Endoparasiticide Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Endoparasiticide Revenue (2021-2032) & (US$ Million) Figure 15. Global Endoparasiticide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Endoparasiticide Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Endoparasiticide Revenue Market Share by Region (2021-2032) Figure 18. Global Endoparasiticide Sales (2021-2032) & (K Units) Figure 19. Global Endoparasiticide Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Endoparasiticide Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Endoparasiticide Sales YoY (2021-2032) & (K Units) Figure 22. Europe Endoparasiticide Sales YoY (2021-2032) & (K Units) Figure 23. China Endoparasiticide Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Endoparasiticide Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Endoparasiticide Sales YoY (2021-2032) & (K Units) Figure 26. Global Endoparasiticide Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Endoparasiticide Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Endoparasiticide Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Endoparasiticide Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Endoparasiticide Revenue Market Share by Type (2021-2032) Figure 32. Global Endoparasiticide Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Endoparasiticide Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Endoparasiticide Sales Market Share by Type (2021-2032) Figure 35. Global Endoparasiticide Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Endoparasiticide Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Endoparasiticide Revenue Market Share by Application (2021-2032) Figure 38. Global Endoparasiticide Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Endoparasiticide Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Endoparasiticide Sales Market Share by Application (2021-2032) Figure 41. North America Endoparasiticide Revenue Share by Type (2021-2032) Figure 42. North America Endoparasiticide Sales Share by Type (2021-2032) Figure 43. North America Endoparasiticide Revenue Share by Application (2021-2032) Figure 44. North America Endoparasiticide Sales Share by Application (2021-2032) Figure 45. North America Endoparasiticide Revenue Share by Country (2021-2032) Figure 46. North America Endoparasiticide Sales Share by Country (2021-2032) Figure 47. Europe Endoparasiticide Revenue Share by Type (2021-2032) Figure 48. Europe Endoparasiticide Sales Share by Type (2021-2032) Figure 49. Europe Endoparasiticide Revenue Share by Application (2021-2032) Figure 50. Europe Endoparasiticide Sales Share by Application (2021-2032) Figure 51. Europe Endoparasiticide Revenue Share by Country (2021-2032) Figure 52. Europe Endoparasiticide Sales Share by Country (2021-2032) Figure 53. China Endoparasiticide Revenue Share by Type (2021-2032) Figure 54. China Endoparasiticide Sales Share by Type (2021-2032) Figure 55. China Endoparasiticide Revenue Share by Application (2021-2032) Figure 56. China Endoparasiticide Sales Share by Application (2021-2032) Figure 57. Asia Endoparasiticide Revenue Share by Type (2021-2032) Figure 58. Asia Endoparasiticide Sales Share by Type (2021-2032) Figure 59. Asia Endoparasiticide Revenue Share by Application (2021-2032) Figure 60. Asia Endoparasiticide Sales Share by Application (2021-2032) Figure 61. Asia Endoparasiticide Revenue Share by Country (2021-2032) Figure 62. Asia Endoparasiticide Sales Share by Country (2021-2032) Figure 63. SAMEA Endoparasiticide Revenue Share by Type (2021-2032) Figure 64. SAMEA Endoparasiticide Sales Share by Type (2021-2032) Figure 65. SAMEA Endoparasiticide Revenue Share by Application (2021-2032) Figure 66. SAMEA Endoparasiticide Sales Share by Application (2021-2032) Figure 67. SAMEA Endoparasiticide Revenue Share by Country (2021-2032) Figure 68. SAMEA Endoparasiticide Sales Share by Country (2021-2032) Figure 69. Endoparasiticide Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Endoparasiticide Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Ear Tags
  • Feed Additives
  • Tablets
  • Injectables
Applications
  • Veterinary Hospitals or Clinics
  • Home Care Settings
  • Animal Farms
Companies covered
  • Novartis AG
  • Merck
  • Eli Lilly
  • Bayer AG
  • Zoetis
  • Virbac
  • Vetoquinol
  • Elanco
  • Ceva Sante Animlae
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Endoparasiticide Market by Type
  3. 1.2.1 Global Endoparasiticide Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Ear Tags
  5. 1.2.3 Feed Additives
  6. 1.2.4 Tablets
  7. 1.2.5 Injectables
  8. 1.3 Endoparasiticide Market by Application
  9. 1.3.1 Global Endoparasiticide Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Veterinary Hospitals or Clinics
  11. 1.3.3 Home Care Settings
  12. 1.3.4 Animal Farms
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Endoparasiticide Market Dynamics
  1. 2.1 Endoparasiticide Industry Trends
  2. 2.2 Endoparasiticide Industry Drivers
  3. 2.3 Endoparasiticide Industry Opportunities and Challenges
  4. 2.4 Endoparasiticide Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Endoparasiticide Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Endoparasiticide Revenue by Region
  3. 3.2.1 Global Endoparasiticide Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Endoparasiticide Revenue by Region (2021-2026)
  5. 3.2.3 Global Endoparasiticide Revenue by Region (2027-2032)
  6. 3.2.4 Global Endoparasiticide Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Endoparasiticide Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Endoparasiticide Sales by Region
  9. 3.4.1 Global Endoparasiticide Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Endoparasiticide Sales by Region (2021-2026)
  11. 3.4.3 Global Endoparasiticide Sales by Region (2027-2032)
  12. 3.4.4 Global Endoparasiticide Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Endoparasiticide Revenue by Manufacturers
  2. 4.1.1 Global Endoparasiticide Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Endoparasiticide Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Endoparasiticide Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Endoparasiticide Sales by Manufacturers
  6. 4.2.1 Global Endoparasiticide Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Endoparasiticide Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Endoparasiticide Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Endoparasiticide Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Endoparasiticide Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Endoparasiticide Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Endoparasiticide Manufacturers, Product Type & Application
  13. 4.7 Global Endoparasiticide Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Endoparasiticide Market CR5 and HHI
  16. 4.8.2 2025 Endoparasiticide Tier 1, Tier 2, and Tier 3
5 Endoparasiticide Market by Type
  1. 5.1 Global Endoparasiticide Revenue by Type
  2. 5.1.1 Global Endoparasiticide Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Endoparasiticide Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Endoparasiticide Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Endoparasiticide Sales by Type
  6. 5.2.1 Global Endoparasiticide Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Endoparasiticide Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Endoparasiticide Sales Market Share by Type (2021-2032)
  9. 5.3 Global Endoparasiticide Price by Type
6 Endoparasiticide Market by Application
  1. 6.1 Global Endoparasiticide Revenue by Application
  2. 6.1.1 Global Endoparasiticide Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Endoparasiticide Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Endoparasiticide Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Endoparasiticide Sales by Application
  6. 6.2.1 Global Endoparasiticide Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Endoparasiticide Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Endoparasiticide Sales Market Share by Application (2021-2032)
  9. 6.3 Global Endoparasiticide Price by Application
7 Company Profiles
  1. 7.1 Novartis AG
  2. 7.1.1 Novartis AG Company Information
  3. 7.1.2 Novartis AG Business Overview
  4. 7.1.3 Novartis AG Endoparasiticide Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis AG Endoparasiticide Product Portfolio
  6. 7.1.5 Novartis AG Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Endoparasiticide Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Endoparasiticide Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 Eli Lilly
  14. 7.3.1 Eli Lilly Company Information
  15. 7.3.2 Eli Lilly Business Overview
  16. 7.3.3 Eli Lilly Endoparasiticide Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Eli Lilly Endoparasiticide Product Portfolio
  18. 7.3.5 Eli Lilly Recent Developments
  19. 7.4 Bayer AG
  20. 7.4.1 Bayer AG Company Information
  21. 7.4.2 Bayer AG Business Overview
  22. 7.4.3 Bayer AG Endoparasiticide Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Bayer AG Endoparasiticide Product Portfolio
  24. 7.4.5 Bayer AG Recent Developments
  25. 7.5 Zoetis
  26. 7.5.1 Zoetis Company Information
  27. 7.5.2 Zoetis Business Overview
  28. 7.5.3 Zoetis Endoparasiticide Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Zoetis Endoparasiticide Product Portfolio
  30. 7.5.5 Zoetis Recent Developments
  31. 7.6 Virbac
  32. 7.6.1 Virbac Company Information
  33. 7.6.2 Virbac Business Overview
  34. 7.6.3 Virbac Endoparasiticide Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Virbac Endoparasiticide Product Portfolio
  36. 7.6.5 Virbac Recent Developments
  37. 7.7 Vetoquinol
  38. 7.7.1 Vetoquinol Company Information
  39. 7.7.2 Vetoquinol Business Overview
  40. 7.7.3 Vetoquinol Endoparasiticide Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Vetoquinol Endoparasiticide Product Portfolio
  42. 7.7.5 Vetoquinol Recent Developments
  43. 7.8 Elanco
  44. 7.8.1 Elanco Company Information
  45. 7.8.2 Elanco Business Overview
  46. 7.8.3 Elanco Endoparasiticide Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Elanco Endoparasiticide Product Portfolio
  48. 7.8.5 Elanco Recent Developments
  49. 7.9 Ceva Sante Animlae
  50. 7.9.1 Ceva Sante Animlae Company Information
  51. 7.9.2 Ceva Sante Animlae Business Overview
  52. 7.9.3 Ceva Sante Animlae Endoparasiticide Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Ceva Sante Animlae Endoparasiticide Product Portfolio
  54. 7.9.5 Ceva Sante Animlae Recent Developments
  55. 7.10 Boehringer Ingelheim
  56. 7.10.1 Boehringer Ingelheim Company Information
  57. 7.10.2 Boehringer Ingelheim Business Overview
  58. 7.10.3 Boehringer Ingelheim Endoparasiticide Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Boehringer Ingelheim Endoparasiticide Product Portfolio
  60. 7.10.5 Boehringer Ingelheim Recent Developments
8 North America
  1. 8.1 North America Endoparasiticide Market Size by Type
  2. 8.1.1 North America Endoparasiticide Revenue by Type (2021-2032)
  3. 8.1.2 North America Endoparasiticide Sales by Type (2021-2032)
  4. 8.1.3 North America Endoparasiticide Price by Type (2021-2032)
  5. 8.2 North America Endoparasiticide Market Size by Application
  6. 8.2.1 North America Endoparasiticide Revenue by Application (2021-2032)
  7. 8.2.2 North America Endoparasiticide Sales by Application (2021-2032)
  8. 8.2.3 North America Endoparasiticide Price by Application (2021-2032)
  9. 8.3 North America Endoparasiticide Market Size by Country
  10. 8.3.1 North America Endoparasiticide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Endoparasiticide Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Endoparasiticide Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Endoparasiticide Market Size by Type
  2. 9.1.1 Europe Endoparasiticide Revenue by Type (2021-2032)
  3. 9.1.2 Europe Endoparasiticide Sales by Type (2021-2032)
  4. 9.1.3 Europe Endoparasiticide Price by Type (2021-2032)
  5. 9.2 Europe Endoparasiticide Market Size by Application
  6. 9.2.1 Europe Endoparasiticide Revenue by Application (2021-2032)
  7. 9.2.2 Europe Endoparasiticide Sales by Application (2021-2032)
  8. 9.2.3 Europe Endoparasiticide Price by Application (2021-2032)
  9. 9.3 Europe Endoparasiticide Market Size by Country
  10. 9.3.1 Europe Endoparasiticide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Endoparasiticide Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Endoparasiticide Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Endoparasiticide Market Size by Type
  2. 10.1.1 China Endoparasiticide Revenue by Type (2021-2032)
  3. 10.1.2 China Endoparasiticide Sales by Type (2021-2032)
  4. 10.1.3 China Endoparasiticide Price by Type (2021-2032)
  5. 10.2 China Endoparasiticide Market Size by Application
  6. 10.2.1 China Endoparasiticide Revenue by Application (2021-2032)
  7. 10.2.2 China Endoparasiticide Sales by Application (2021-2032)
  8. 10.2.3 China Endoparasiticide Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Endoparasiticide Market Size by Type
  2. 11.1.1 Asia Endoparasiticide Revenue by Type (2021-2032)
  3. 11.1.2 Asia Endoparasiticide Sales by Type (2021-2032)
  4. 11.1.3 Asia Endoparasiticide Price by Type (2021-2032)
  5. 11.2 Asia Endoparasiticide Market Size by Application
  6. 11.2.1 Asia Endoparasiticide Revenue by Application (2021-2032)
  7. 11.2.2 Asia Endoparasiticide Sales by Application (2021-2032)
  8. 11.2.3 Asia Endoparasiticide Price by Application (2021-2032)
  9. 11.3 Asia Endoparasiticide Market Size by Country
  10. 11.3.1 Asia Endoparasiticide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Endoparasiticide Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Endoparasiticide Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Endoparasiticide Market Size by Type
  2. 12.1.1 SAMEA Endoparasiticide Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Endoparasiticide Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Endoparasiticide Price by Type (2021-2032)
  5. 12.2 SAMEA Endoparasiticide Market Size by Application
  6. 12.2.1 SAMEA Endoparasiticide Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Endoparasiticide Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Endoparasiticide Price by Application (2021-2032)
  9. 12.3 SAMEA Endoparasiticide Market Size by Country
  10. 12.3.1 SAMEA Endoparasiticide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Endoparasiticide Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Endoparasiticide Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Endoparasiticide Value Chain Analysis
  2. 13.1.1 Endoparasiticide Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Endoparasiticide Production Mode & Process
  6. 13.2 Endoparasiticide Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Endoparasiticide Distributors
  9. 13.2.3 Endoparasiticide Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst